Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1204 | 1032 | 1353 | 1380 | 1916 | 3428 |
Fund Return | 20.37% | 3.22% | 35.27% | 11.35% | 13.89% | 13.11% |
Place in category | 9 | 7 | 17 | 7 | 16 | 9 |
% in Category | 11 | 11 | 24 | 20 | 58 | 65 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BoseraYufu CSI 300 Index Fund A | 7.14B | 14.03 | -4.52 | 8.55 | ||
BoseraYufu CSI 300 Index Fund C | 7.14B | 13.64 | -4.90 | - | ||
Bosera Theme Industry Stock FdLOF | 5.72B | 0.69 | -12.06 | 7.64 | ||
Bosera MedicalHlth Care Set Secs A | 2.56B | -10.44 | -17.18 | 5.39 | ||
Bosera Value Growth Fund | 2.01B | 11.03 | -5.83 | 3.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDIII | 12.49B | 17.64 | 10.21 | 17.76 | ||
HuaAn NASDAQ 100 Index QDII RMB | 5.3B | 16.82 | 10.11 | 17.22 | ||
Harvest U.S. Growth Equity QDII RMB | 4.1B | 24.15 | 11.89 | 14.67 | ||
Dacheng NASDAQ 100 Index Fund QDII | 4.09B | 16.13 | 10.38 | - | ||
Guotai NASDAQ 100 Index Fund QDII | 2.26B | 18.22 | 10.87 | 18.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.79 | 412.87 | -0.43% | |
NVIDIA | US67066G1040 | 6.21 | 146.67 | +0.53% | |
Apple | US0378331005 | 6.21 | 228.52 | -0.21% | |
Amazon.com | US0231351067 | 3.62 | 198.38 | -2.22% | |
Meta Platforms | US30303M1027 | 2.26 | 563.09 | -0.43% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review